GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: REGN-910 | REGN910 | SAR307746
Compound class:
Antibody
Comment: Nesvacumab is a fully human monoclonal antibody that targets angiopoietin-2 (ANGPT2, aka ANG2), being investigated as an antiangiogenic anti-tumour agent.
Peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
| Bioactivity Comments |
| Nesvacumab is reported to disrupt Tie2-mediated signalling in preclinical studies [1]. |
| Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||